Overview
- Editors:
-
-
Douglas L. Mayers
-
Executive Vice President & Chief Medical Offi cer, Idenix Pharmaceuticals, Cambridge, USA
Access this book
Other ways to access
Table of contents (46 chapters)
-
Front Matter
Pages i-xxvi
-
General Overview
-
-
- Fernando Baquero, Rafael Cantón
Pages 9-32
-
-
- David M. Shlaes, Steven J. Projan
Pages 43-50
-
General Mechanisms of Drug Resistance
-
-
- Maja Babic, Robert A. Bonomo
Pages 65-74
-
-
- Vanessa D'Costa, Gerard D. Wright
Pages 81-95
-
- Joseph B. McPhee, Sandeep Tamber, Michelle D. Brazas, Shawn Lewenza, Robert E. W. Hancock
Pages 97-110
-
- Adrian R. Walmsley, Barry P. Rosen
Pages 111-120
-
- Christoph A. Fux, Paul Stoodley, Mark Shirtliff, J. William Costerton
Pages 121-131
-
Bacterial Drug Resistance – Mechanisms
-
-
- André Zapun, Pauline Macheboeuf, Thierry Vernet
Pages 145-170
-
- Maria L. Magalhães, John S. Blanchard
Pages 171-181
-
- Marilyn C. Roberts, Stefan Schwarz
Pages 183-193
-
- Varsha V. Moudgal, Glenn W. Kaatz
Pages 195-205
-
-
- Annie Canu, Roland Leclercq
Pages 211-221
-
- Abhay Dhand, David R. Snydman
Pages 223-227
About this book
This ? rst edition of Antimicrobial Drug Resistance grew out of a desire by the editors and authors to have a comprehensive resource of information on antimicrobial drug resistance that encompassed the current information available for bacteria, fungi, protozoa and viruses. We believe that this information will be of value to clinicians, epidemiologists, microbiologists, virologists, parasitologists, public health authorities, medical students and fellows in training. We have endeavored to provide this information in a style which would be accessible to the broad community of persons who are concerned with the impact of drug resistance in our cl- ics and across the broader global communities. Antimicrobial Drug Resistance is divided into Volume 1 which has sections covering a general overview of drug resistance and mechanisms of drug resistance ? rst for classes of drugs and then by individual microbial agents including bacteria, fungi, protozoa and viruses. Volume 2 addresses clinical, epidemiologic and public health aspects of drug resistance along with an overview of the conduct and interpretation of speci? c drug resistance assays. Together, these two volumes offer a comprehensive source of information on drug resistance issues by the experts in each topic.
Reviews
From the reviews:
“This weighty tome … provides a series of reviews by internationally respected authors, including Drs Baquero, Bush, LeClercq, Jacoby and many more. … Overall, a worthwhile reference work for institutional libraries and for scientists with broad interests in the field of resistance.” (David Livermore, Microbiology Today, January, 2010)
Editors and Affiliations
-
Executive Vice President & Chief Medical Offi cer, Idenix Pharmaceuticals, Cambridge, USA
Douglas L. Mayers
